As well, we found that high expression of UGT2B4 was associated with upregulated tumor metabolic pathways such as 'de novo' IMP biosynthetic process, glutamine and monocarboxylic acid metabolism (Figure 5D). This evidence concerns the gene UGT2B4 and neoplasm.